Medicare Enrolled
Dr. Howard Zipin, M.D.
Hematology & Oncology · Sellersville, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zipin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zipin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zipin
Dr. Howard Zipin is a hematology & oncology specialist in Sellersville, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zipin performed 115,562 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Zipin received a total of $25,652 from 100 pharmaceutical and/or device companies across 771 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zipin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in PA
$25,652 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗115,562
Medicare services
Top 4% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
36,740 | $2 | $21 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
33,000 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 15,180 | $18 | $68 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
13,500 | $0 | $6 |
| Iron infusion (Monoferric) | 3,200 | $16 | $73 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,013 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,121 | $1 | $123 |
| Injection, leucovorin calcium, per 50 mg | 936 | $3 | $27 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
855 | $8 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
817 | $13 | $105 |
| Injection, granisetron hydrochloride, 100 mcg | 740 | $0 | $25 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
654 | $2 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
589 | $104 | $224 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
553 | $8 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
496 | $12 | $93 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
376 | $62 | $205 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
363 | $113 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $70 | $148 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
305 | $2 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
166 | $66 | $157 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
159 | $25 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
153 | $55 | $304 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
152 | $1 | $7 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
127 | $1 | $9 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $130 | $344 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $24 | $156 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
93 | $70 | $214 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
82 | $56 | $334 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
76 | $11 | $73 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
74 | $47 | $281 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
74 | $149 | $986 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
74 | $2 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
71 | $17 | $97 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
59 | $20 | $111 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $150 | $301 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
48 | $28 | $249 |
| New patient office visit, complex (60-74 min) | 28 | $156 | $432 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $48 | $88 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $100 | $232 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
19 | $32 | $240 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $109 | $297 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
18 | $42 | $115 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
18 | $1 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
32.2% high complexity
65.2% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,652
Total received (2018-2024)
Avg $3,665/year across 7 years
Top 13% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
100
Companies
771
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,385
2023
$2,785
2022
$2,341
2021
$5,990
2020
$1,490
2019
$5,650
2018
$3,011
Payments by company (2024)
BeiGene USA, Inc.
$1,971
Novartis Pharmaceuticals Corporation
$209
ABBVIE INC.
$199
Daiichi Sankyo Inc.
$188
AstraZeneca Pharmaceuticals LP
$146
Takeda Pharmaceuticals U.S.A., Inc.
$131
Lilly USA, LLC
$110
PFIZER INC.
$110
Genentech USA, Inc.
$95
Genmab U.S., Inc.
$89
Blueprint Medicines Corporation
$87
Incyte Corporation
$83
SOBI, INC
$70
Merck Sharp & Dohme LLC
$65
GlaxoSmithKline, LLC.
$65
Regeneron Healthcare Solutions, Inc.
$53
Bayer Healthcare Pharmaceuticals Inc.
$50
Janssen Biotech, Inc.
$47
Exelixis Inc.
$47
Alexion Pharmaceuticals, Inc.
$44
Gilead Sciences, Inc.
$44
Tempus AI, Inc
$44
E.R. Squibb & Sons, L.L.C.
$43
Ipsen Biopharmaceuticals, Inc
$41
Acrotech Biopharma Inc.
$35
Eisai Inc.
$33
Karyopharm Therapeutics Inc.
$31
ImmunoGen, Inc.
$30
PharmaEssentia USA Corporation
$29
Celgene Corporation
$29
ARRAY BIOPHARMA INC
$27
EMD Serono, Inc.
$24
Rigel Pharmaceuticals, Inc.
$23
SpringWorks Therapeutics, Inc.
$22
GENZYME CORPORATION
$20
Telix Pharmaceuticals
$18
Pharmacosmos Therapeutics Inc.
$17
Aveo Pharmaceuticals, Inc.
$17
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$4,123
E.R. Squibb & Sons, L.L.C.
$2,501
Karyopharm Therapeutics Inc.
$2,420
BeiGene USA, Inc.
$2,065
Janssen Biotech, Inc.
$2,043
AstraZeneca Pharmaceuticals LP
$1,062
Genentech USA, Inc.
$784
Daiichi Sankyo Inc.
$670
Astellas Pharma US Inc
$555
PFIZER INC.
$514
Incyte Corporation
$447
GENZYME CORPORATION
$426
Lilly USA, LLC
$412
Takeda Pharmaceuticals U.S.A., Inc.
$397
Amgen Inc.
$387
Merck Sharp & Dohme Corporation
$365
Pharmacyclics LLC, An AbbVie Company
$308
Merck Sharp & Dohme LLC
$302
Celgene Corporation
$289
Seagen Inc.
$262
Genmab U.S., Inc.
$242
GlaxoSmithKline, LLC.
$237
ABBVIE INC.
$235
Bayer HealthCare Pharmaceuticals Inc.
$222
Eisai Inc.
$175
Exelixis Inc.
$156
Rigel Pharmaceuticals, Inc.
$153
Gilead Sciences, Inc.
$151
ADC Therapeutics America, Inc.
$142
Pharmacyclics LLC, an AbbVie Company
$142
Ipsen Biopharmaceuticals, Inc
$139
Blueprint Medicines Corporation
$138
SOBI, INC
$136
Alexion Pharmaceuticals, Inc.
$132
EMD Serono, Inc.
$123
Bayer Healthcare Pharmaceuticals Inc.
$119
Regeneron Healthcare Solutions, Inc.
$112
JAZZ PHARMACEUTICALS INC.
$112
TESARO, Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
TerSera Therapeutics LLC
$97
Dendreon Pharmaceuticals LLC
$93
Pharmacosmos Therapeutics Inc.
$86
EISAI INC.
$71
Myriad Genetic Laboratories, Inc.
$70
Stemline Therapeutics Inc.
$69
MorphoSys, US Inc.
$68
Epizyme, Inc.,
$66
ARRAY BIOPHARMA INC
$64
SANOFI-AVENTIS U.S. LLC
$54
Apellis Pharmaceuticals, Inc.
$52
Seattle Genetics, Inc.
$51
AbbVie, Inc.
$49
Janssen Pharmaceuticals, Inc
$48
GE HealthCare
$47
Foundation Medicine, Inc.
$47
Jazz Pharmaceuticals Inc.
$46
Progenics Pharmaceuticals, Inc.
$45
Alnylam Pharmaceuticals Inc.
$45
Welch Allyn
$44
AbbVie Inc.
$44
Tempus AI, Inc
$44
Lexicon Pharmaceuticals, Inc.
$43
Puma Biotechnology, Inc.
$41
Kite Pharma, Inc.
$39
SUN PHARMACEUTICAL INDUSTRIES INC.
$38
Teva Pharmaceuticals USA, Inc.
$37
Dova Pharmaceuticals
$36
AMAG Pharmaceuticals, Inc.
$35
Mirati Therapeutics, Inc.
$35
Acrotech Biopharma Inc.
$35
Aveo Pharmaceuticals, Inc.
$33
Global Blood Therapeutics, Inc.
$31
Clovis Oncology, Inc.
$31
Mylan Institutional Inc.
$31
ImmunoGen, Inc.
$30
PharmaEssentia USA Corporation
$29
Taiho Oncology, Inc.
$27
Myovant Sciences Inc.
$25
Shire North American Group Inc
$24
Sobi, Inc
$23
SpringWorks Therapeutics, Inc.
$22
Coherus Biosciences Inc.
$21
Sun Pharmaceutical Industries Inc.
$21
Kyowa Kirin, Inc.
$20
Verastem, Inc.
$20
Spectrum Pharmaceuticals Inc.
$20
Fortovia Therapeutics, Inc.
$19
Telix Pharmaceuticals
$18
GE HEALTHCARE
$18
TAIHO ONCOLOGY, INC.
$18
Verity Pharmaceuticals Inc.
$18
Innate Pharma, Inc
$17
Adaptive Biotechnologies Corporation
$15
Secura Bio, Inc.
$13
Deciphera Pharmaceuticals Inc.
$12
Aurobindo Pharma USA, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Akcea Therapeutics, Inc.
$11
Array BioPharma Inc.
$11
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erivedge · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GATTEX · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kovaltry · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · MYRISK · Marqibo · Monoferric · NINLARO · Nerlynx · Neulasta · None · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · QUZYTTIR · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TEGSEDI · TEVIMBRA · TIVDAK · TRUSELTIQ · TUKYSA · Tavalisse · Tecentriq · Tivdak · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vanflyta · Venclexta · WAINUA · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
120
County median income
$111,951
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S HOSPITAL - GRAND VIEW CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zipin is a mixed practice specialist, with above-average Medicare volume (top 4% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zipin experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Zipin performed 36,740 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zipin receive payments from pharmaceutical companies?
Yes. Dr. Zipin received a total of $25,652 from 100 companies across 771 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zipin's costs compare to other hematology & oncology specialists in Sellersville?
Dr. Zipin's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zipin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sellersville
Browse hematology & oncology specialists in Sellersville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology